# NuclixBio - **Website:** - **Primary alias:** `nuclixbio.com` - **Founded:** 2017 - **Employees:** 11+ - **Location:** Seoul, Seoul, South Korea - **Company kind:** PRIVATELY HELD ## Description NuclixBio is a pioneering brand that focuses on the early-stage research and development of intracellularly targeted nucleic acid therapeutics. With an unwavering dedication to "Drugging the Undruggable," NuclixBio utilizes its proprietary platform technologies to create next-generation targeted therapeutics. Their innovative Circular mRNA platform and Aptamer-Drug Conjugates set NuclixBio apart as leaders in the field. These cutting-edge technologies pave the way for the treatment of previously "Undruggable" targets, opening new possibilities in the medical world. Composed of a team of nucleic acid engineering experts, NuclixBio is always open to collaborations and partnerships for further advancements. They welcome questions and ideas, encouraging a cooperative approach to revolutionizing medicine. Based in Seoul, Republic of Korea, NuclixBio's headquarters can be found at 801, Digital-ro 33-gil 28, Guro-gu. For inquiries, you can reach them at +82-2-6951-5893 or via email at nuclixbio@nuclixbio.com. Experience the future of targeted therapeutics with NuclixBio, where groundbreaking science meets innovative solutions. Copyright © 2021 NuclixBio. All rights reserved. ## Industries - ⛑ Biotechnology and Pharmaceuticals _(under Health)_ - ⛑ Health ## Logos & icons - logo _(primary)_ — PNG — [download](https://cdn.brandfetch.io/id1ZI7C3V3/w/232/h/53/theme/dark/logo.png?c=1bxid64Mup7aczewSAYMX&t=1756364927335) ## Colors | Name | Hex | Theme | | --- | --- | --- | | Royal Blue | #1a73e8 | accent | | Shark | #202124 | dark | | White | #ffffff | light | ## Fonts - Noto Sans KR — asset _(google)_ - Noto Sans — asset _(google)_ --- _Source: _ _See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._